Crossref Community Call May 2016
•Download as PPT, PDF•
1 like•570 views
Crossref presented these slides to the public on May 23, 2016 as a update on the status of several key Crossref initiatives, including enabling the acceptance of preprints, early content registration, and an early preview of Crossref Event Data, improvements to the CrossMark dialog box. Other topics included the growth of the Crossref membership, and the launch of a new logo and new product names as part of Crossref re-branding. Speakers included Daniel Shanahan of BioMedCentral and Ed Pentz, Ginny Hendricks, Geoffrey Bilder, Jennifer Lin, Maddy Watson, Kirsty Meddings, Chuck Koscher of Crossref.
Recommended
More Related Content
What's hot
What's hot (20)
Similar to Crossref Community Call May 2016
Similar to Crossref Community Call May 2016 (20)
More from Crossref
More from Crossref (20)
Recently uploaded
Recently uploaded (20)
Crossref Community Call May 2016
- 2. First Communit y Call 23rd May 2016
- 3. Agenda Ed Pentz, Executive Director Ginny Hendricks, Director Membership & Outreach Geoffrey Bilder, Director of Strategic Initiatives Jennifer Lin, Director of Product Management Daniel Shanahan, Publisher (BioMed Central) Kirsty Meddings, Product Manager Madeleine Watson, Product Manager Chuck Koscher, Director of Technology 1. Crossref Latest …………… 2. Rebrand Rollout …………. 3. Preprints at Crossref …….. 4. Early Content Registration.. 5. Linked Clinical Trials……… 6. CrossMark Dialog Box …… 7. Event Data Preview ……… 8. ORCID Auto-Update ……..
- 4. What’s the latest at Crossref? Ed Pentz Executive Director @epentz
- 9. • Journals • Books • Conference proceedings • Standards • Technical reports • Working Papers • Theses and dissertations • Components (figures, tables) • Datasets (supplementary data) • Databases
- 11. Agenda Ed Pentz, Executive Director Ginny Hendricks, Director Membership & Outreach Geoffrey Bilder, Director of Strategic Initiatives Jennifer Lin, Director of Product Management Daniel Shanahan, Publisher (BioMed Central) Kirsty Meddings, Product Manager Madeleine Watson, Product Manager Chuck Koscher, Director of Technology 1. Welcome & Latest ………... 2. Rebrand Rollout …………. 3. Preprints at Crossref …….. 4. Early Content Registration.. 5. Linked Clinical Trials……… 6. CrossMark Dialog Box …… 7. Event Data Preview ……… 8. ORCID Auto-Update ……..
- 12. We rebranded! Now what? Ginny Hendricks Director of Member & Community Outreach @GinnyLDN
- 20. Agenda Ed Pentz, Executive Director Ginny Hendricks, Director Membership & Outreach Geoffrey Bilder, Director of Strategic Initiatives Jennifer Lin, Director of Product Management Daniel Shanahan, Publisher (BioMed Central) Kirsty Meddings, Product Manager Madeleine Watson, Product Manager Chuck Koscher, Director of Technology 1. Welcome & Latest ………... 2. Rebrand Rollout …………. 3. Preprints at Crossref …….. 4. Early Content Registration.. 5. Linked Clinical Trials……… 6. CrossMark Dialog Box …… 7. Event Data Preview ……… 8. ORCID Auto-Update ……..
- 21. Crossref for Preprints Geoffrey Bilder Director of Strategic Initiatives @gbilder
- 22. ~ 1999-2000
- 23. “Cannot assign Crossref DOIs to duplicative works”
- 24. Except for….
- 25. Reprints
- 26. Translations
- 28. “publish ahead of print” “online ahead of print” “article in progress” “article in press” “online first” etc.
- 30. “Cannot assign Crossref DOIs to duplicative works”
- 33. Like a version
- 34. submission acceptance publication authors original accepted manuscript postprint u-vor/e-vor JAV Common Usage http://en.wikipedia.org/wiki/Preprint submitted manuscript under review Citation record preprint final published version version of record u-vor/e-vor preprint updated enhanced onlinewithDOI publisher citable version https://en.wikipedia.org/wiki/Postprint
- 35. The new rules…
- 36. a CR DOI assigned to an accepted manuscript, must be assigned by the CR member who accepted the manuscript for publication.
- 37. When a CR DOI is assigned to an accepted manuscript (AM), the same Crossref DOI should be used for the version of record (VOR) as well.
- 38. Preprints may be assigned CR DOIs by the CR member hosting the preprint.
- 39. preprint DOIs must link to published version DOI if/when there is one available
- 40. (crossref will provide tools to make this easier)
- 41. preprint versions must be labelled clearly as such
- 42. published DOIs may link to preprint version if/if it has a DOI
- 43. all Crossref tools and APIs will privilege later versions
- 44. Thanks
- 45. Agenda Ed Pentz, Executive Director Ginny Hendricks, Director Membership & Outreach Geoffrey Bilder, Director of Strategic Initiatives Jennifer Lin, Director of Product Management Daniel Shanahan, Publisher (BioMed Central) Kirsty Meddings, Product Manager Madeleine Watson, Product Manager Chuck Koscher, Director of Technology 1. Welcome & Latest ………... 2. Rebrand Rollout …………. 3. Preprints at Crossref …….. 4. Early Content Registration.. 5. Linked Clinical Trials……… 6. CrossMark Dialog Box …… 7. Event Data Preview ……… 8. ORCID Auto-Update ……..
- 46. Early Content Registration Jennifer Lin Director of Product Management @jenniferlin15
- 47. Current Issues • broken links from unregistered DOIs undermine trust in persistent links and availability of content • publishers- • cannot meet funder mandates that focus on acceptance point for reporting • advance publicity & press leave out DOIs or lead to broken links • researchers - cannot provide evidence of all publications in grant and employment applications • funders & institutions - cannot fully track research they support
- 49. Early Content Registration Coming in August! Acceptance Publication • Early Content Registration • DOI is ‘live’ • Intent to publish statement displayed (Crossref-hosted) • Full Content Registration • DOI resolves to publication • Intent to publish statement is replaced
- 50. Metadata Requirements Must include •DOI •Date of acceptance •Publisher name •Journal/Book/Conference title •"Intent to publish” statement (provided by publisher or Crossref in its absence) Should include •Funding information (Open Funder Registry) •ORCID iDs •License •Author affiliation •ISSN/ISBN May include •Publisher logo •Custom "intent to publish” statement •Publication title •Item title (e.g. article title)
- 51. Withdrawals - CrossMark Publication record information: •publication status • publication history • ORCIDs & contribution (CReDiT) • clinical trial information • rights or licensing information • funding information • peer review processes • conflict of interest disclosures • plagiarism or similarity screening status • links to datasets, software, protocols, materials…
- 53. an open scholarly map for the whole research enterprise
- 54. Who uses the Crossref scholarly roadmap? • Funders • Institutions • Archives & repositories • Research councils • Data centres • Professional networks • Patent offices • Indexing services • Publishing vendors • Peer review systems • Reference manager systems • Lab & diagnostics suppliers • Info mgmt systems • Educational tools • Data analytics systems • Literature discovery services • Registration Agencies
- 55. Thank you Noun Project contributors: BlueTip Design, Jose Moya, Gira Park, Jérôme Poslednik, Adame Dahmani, Simple Icons, Mani Amini Jennifer Lin, PhD jlin@crossref.org @jenniferlin15 orcid.org/0000-0002-9680-2328
- 56. Agenda Ed Pentz, Executive Director Ginny Hendricks, Director Membership & Outreach Geoffrey Bilder, Director of Strategic Initiatives Jennifer Lin, Director of Product Management Daniel Shanahan, Publisher (BioMed Central) Kirsty Meddings, Product Manager Madeleine Watson, Product Manager Chuck Koscher, Director of Technology 1. Welcome & Latest ………... 2. Rebrand Rollout …………. 3. Preprints at Crossref …….. 4. Early Content Registration.. 5. Linked Clinical Trials……… 6. CrossMark Dialog Box …… 7. Event Data Preview ……… 8. ORCID Auto-Update ……..
- 57. Linked Clinical Trials Daniel Shanahan, BioMed Central
- 58. Agenda Ed Pentz, Executive Director Ginny Hendricks, Director Membership & Outreach Geoffrey Bilder, Director of Strategic Initiatives Jennifer Lin, Director of Product Management Daniel Shanahan, Publisher (BioMed Central) Kirsty Meddings, Product Manager Madeleine Watson, Product Manager Chuck Koscher, Director of Technology 1. Welcome & Latest ………... 2. Rebrand Rollout …………. 3. Preprints at Crossref …….. 4. Early Content Registration.. 5. Linked Clinical Trials……… 6. CrossMark Dialog Box …… 7. Event Data Preview ……… 8. ORCID Auto-Update ……..
- 59. A new look for CrossMark Kirsty Meddings Product Manager @kmeddings
- 62. Why? • More room for more metadata • No second click • Fresh and contemporary flat design • Responsive on mobile devices (coming soon)
- 68. Agenda Ed Pentz, Executive Director Ginny Hendricks, Director Membership & Outreach Geoffrey Bilder, Director of Strategic Initiatives Jennifer Lin, Director of Product Management Daniel Shanahan, Publisher (BioMed Central) Kirsty Meddings, Product Manager Madeleine Watson, Product Manager Chuck Koscher, Director of Technology 1. Welcome & Latest ………... 2. Rebrand Rollout …………. 3. Preprints at Crossref …….. 4. Early Content Registration.. 5. Linked Clinical Trials……… 6. CrossMark Dialog Box …… 7. Event Data Preview ……… 8. ORCID Auto-Update ……..
- 69. Early Preview of Crossref Event Data Madeleine Watson Product Manager @mwats0n
- 74. Agenda Ed Pentz, Executive Director Ginny Hendricks, Director Membership & Outreach Geoffrey Bilder, Director of Strategic Initiatives Jennifer Lin, Director of Product Management Daniel Shanahan, Publisher (BioMed Central) Kirsty Meddings, Product Manager Madeleine Watson, Product Manager Chuck Koscher, Director of Technology 1. Welcome & Latest ………... 2. Rebrand Rollout …………. 3. Preprints at Crossref …….. 4. Early Content Registration.. 5. Linked Clinical Trials……… 6. CrossMark Dialog Box …… 7. Event Data Preview ……… 8. ORCID Auto-Update ……..
- 75. Status: ORCID Auto-Update Chuck Koscher Director of Technology @ckoscher
- 77. How’s it going? Articles with at least one author ORCID: Publishers depositing ORCIDs: Requests sent to authors for permission: Permission not given (or no response): Works pushed to author profiles: 363,478 480 256,667 155,300 153,254
- 78. Issues to consider When publishers update their deposited metadata, should Crossref re-push the work to the author’s profile, should the author be notified? What can be done to improve the conversion rate for permission requests? Encourage publishers to validate the ORCID given by the author.
- 80. Keep in touch • Ideas for community call topics (or anything else you want to see us do) - email feedback@crossref.org • Sign up for blog posts by email - blog.crossref.org • Come and see us at SSP in Vancouver next week - booth 204A
Editor's Notes
- Registering content with Crossref prior to online availability will improve things and make the Crossref metadata and Crossref DOIs even more useful. In particular for journal articles, registering content, including the DOI, at acceptance enables formal evidence of impending publication for disclosure to all interested stakeholders. Publishers can: inform the user that the DOI followed is not yet available without serving an error. inform the user to use the provided DOI to link to the content as it will imminently resolve to the publisher stewarded copy. provide metadata for use by funders and institutions to detect and flag impending publications that are relevant to them and ensure that Institutional Repositories will use the DOI to link to the publisher stewarded copy. registering the Accepted Manuscript guarantees that the DOI link is active at the exact moment in which the publication is made available. Authors, institutions, and publishers can immediately publicise the availability of the article (e.g. tweeting, emailing it to colleagues). Journalists can write their story during press embargo with a proper citation to the publication for release as soon as publication is available. Technology providers can better support the wide host of parties who desire to track scholarly publications.
- https://docs.google.com/spreadsheets/d/1E7hEnHkhzsl8nxay5Toy449fzAfWow62tKrRNVCULPw/edit#gid=756390039
- The metadata is all standardised, centralised and freely available. And the CrossMark on the journal pages gives the reader up to date information that they need.
- LINK IT UP AS EARLY AS POSSIBLE. map of research outputs and artifacts, funders, researchers, data, software, blog mentions, social media shares, Wikipedia references, scholarly citations, etc. all linked up in a massive graph. ALL OF THIS FORMS THE WEBBING OF SCHOLARLY COMMUNICATIONS.
- Launched in 2012 after lengthy pilot